Delivery Order SPE2DB25D2207-SPE2DB25FQPSY

Award Date 10/29/24
Potential Completion Date 10/30/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML vaccine to the Defense Logistics Agency (DLA). The $2,791.15 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has an ultimate completion date of November 4, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves...
This federal contract award is for the delivery of PEDIARIX 0.5 ML syringes, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $16,979.93. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of July 24, 2024. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The award, valued at $4,315.70, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 4, 2024. It is not designated as a set-aside contract. Amerisourcebergen...
This federal contract award is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML to the Defense Logistics Agency (DLA). The contract, valued at $5,996.40, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and the ultimate completion date is February 26, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,032.14 firm fixed-price delivery order is for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML, a medical product used for pediatric vaccination. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, issued by the Defense Logistics Agency (DLA), was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,332.30 firm fixed-price delivery order contract is for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pediatric vaccine product. The contract has an ultimate completion date of January 13, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,264.40 Firm Fixed Price delivery order is for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pediatric vaccine product. The contract has a completion date of February 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,804.36 firm fixed-price delivery order is for the procurement of PEDIARIX 0.5 ML SYRINGE 0.5ML, which supports military healthcare programs. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for...
This is a federal delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $6,651.70 firm-fixed-price award is for the supply of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pediatric vaccine product. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide PEDIARIX 0.5 ML SYRINGE 0.5ML. The $1,969.05 delivery order was placed under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran...
  • SPE2DB25D2207
    Indefinite Delivery Contract
  • SPE2DB25D2207-SPE2DB25FQPSY
    Delivery Order

The federal contract award is for the delivery of PEDIARIX 0.5 ML SYRINGE 0.5ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,939.40 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which covers a comprehensive range of pharmaceutical and medical supply products to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. This delivery order contributes to the company's significant role as a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems.

Generated 1/28/25, 12:23 PM